Scott Kelly will be presenting at the Triple Negative Breast Cancer Drug Development Summit, April 28th.

Scroll down to 4:30pm on the agenda.

https://tnbc-summit.com/program/agenda/

Quote:

---

4:30 pm The Role of Leronlimab to Treat TNBC

Scott Kelly
Chief Medical Officer , Cytodyn

Synopsis

• Mechanisms of action of Leronlimab
• Leronlimab in the tumor microenvironment

---